Eli Lilly and Company has become a key player in the manufacturing of tirzepatide, a groundbreaking medication for type 2 diabetes. Tirzepatide, a dual GIP and GLP-1 receptor agonist, exhibits significant capacity to improve glycemic control and reduce heart disease. The intricate production method of tirzepatide involves a series of meticulous pro